PlainRecalls
FDA Drug Moderate Class II Terminated

Erythromycin Topical Gel USP, 2%, Net Wt 30 g tube, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation, dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-053-66.

Reported: February 23, 2022 Initiated: February 7, 2022 #D-0716-2022

Product Description

Erythromycin Topical Gel USP, 2%, Net Wt 30 g tube, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation, dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-053-66.

Reason for Recall

Failed Impurities/Degradation Specifications: Lot not meeting specification for Unknown Max Related Compounds.

Details

Recalling Firm
Teligent Pharma, Inc.
Units Affected
11040 tubes
Distribution
Nationwide in the USA.
Location
Buena, NJ

Frequently Asked Questions

What product was recalled?
Erythromycin Topical Gel USP, 2%, Net Wt 30 g tube, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation, dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-053-66.. Recalled by Teligent Pharma, Inc.. Units affected: 11040 tubes.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Lot not meeting specification for Unknown Max Related Compounds.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 23, 2022. Severity: Moderate. Recall number: D-0716-2022.